| TEAS for Sedation During ERCP: A Multicenter Trial With Mechanistic Substudy (NCT07440342) | Beijing 302 Hospital | 2026-09-01 |
| Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study (NCT07637877) | Beijing 302 Hospital | 2026-06-15 |
| VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial (NCT07514832) | Beijing 302 Hospital | 2026-04-15 |
| Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia (NCT07297173) | Beijing 302 Hospital | 2025-12-01 |
| Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor (NCT06556862) | Beijing 302 Hospital | 2025-10-01 |
| TEAS for Variceal Bleeding Endoscopy in Cirrhosis (NCT07106658) | Beijing 302 Hospital | 2025-07-18 |
| Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML (NCT07078591) | Beijing 302 Hospital | 2025-06-20 |
| Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS (NCT07238686) | Beijing 302 Hospital | 2025-06-20 |
| A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B (NCT06926647) | Beijing 302 Hospital | 2025-05-01 |
| Rapid Diagnostic Technology for AUGIB Based on Analysis of VOCs in Exhaled Breath (NCT06877507) | Beijing 302 Hospital | 2025-03-20 |
| Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML (NCT06741722) | Beijing 302 Hospital | 2024-10-31 |
| Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis (NCT06418594) | Beijing 302 Hospital | 2024-10-10 |
| Antiviral Therapy in Infants With HBV Infection (NCT06503796) | Beijing 302 Hospital | 2024-08-01 |
| VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS (NCT06536959) | Beijing 302 Hospital | 2024-07-18 |
| Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) (NCT05224960) | Beijing 302 Hospital | 2024-06-27 |
| Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients (NCT06457477) | Beijing 302 Hospital | 2024-06-15 |
| The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients (NCT06357806) | Beijing 302 Hospital | 2024-05-17 |
| Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma (NCT06364787) | Beijing 302 Hospital | 2024-04-26 |
| Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody (NCT06364800) | Beijing 302 Hospital | 2024-04-26 |
| Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade (NCT06238245) | Beijing 302 Hospital | 2024-02-28 |
| Clinical Trial of Metal-Reinforced Teeth Designed for Endoscopic Clips (NCT06285955) | Beijing 302 Hospital | 2024-02-15 |
| Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis (NCT06392503) | Beijing 302 Hospital | 2023-11-30 |
| Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure (NCT05985863) | Beijing 302 Hospital | 2023-09-30 |
| Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases (NCT06236594) | Beijing 302 Hospital | 2023-09-18 |
| Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b) (NCT05984303) | Beijing 302 Hospital | 2023-08-30 |
| Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B (NCT05905731) | Beijing 302 Hospital | 2023-06-01 |
| HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC (NCT05834699) | Beijing 302 Hospital | 2023-01-01 |
| HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC (NCT05834686) | Beijing 302 Hospital | 2023-01-01 |
| Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study (NCT05586841) | Beijing 302 Hospital | 2022-10-01 |
| Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1) (NCT05227846) | Beijing 302 Hospital | 2022-03-22 |
| Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer (NCT05273541) | Beijing 302 Hospital | 2022-02-11 |
| Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer (NCT05402722) | Beijing 302 Hospital | 2022-01-01 |
| Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC (NCT06059885) | Beijing 302 Hospital | 2021-12-22 |
| Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy (NCT05057104) | Beijing 302 Hospital | 2021-10-10 |
| Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (NCT05121870) | Beijing 302 Hospital | 2021-09-01 |
| Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV (NCT05085145) | Beijing 302 Hospital | 2021-09-01 |
| A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients (NCT05017714) | Beijing 302 Hospital | 2021-08-31 |
| Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer (NCT05018078) | Beijing 302 Hospital | 2021-08-30 |
| COVID-19 Vaccines in Patients With Chronic Liver Disease (NCT05017805) | Beijing 302 Hospital | 2021-08-15 |
| Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults (NCT05012800) | Beijing 302 Hospital | 2021-07-28 |
| Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection (NCT04863066) | Beijing 302 Hospital | 2021-05-01 |
| Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib (NCT06135194) | Beijing 302 Hospital | 2021-04-01 |
| Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years (NCT04565262) | Beijing 302 Hospital | 2020-09-01 |
| Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial (NCT04518774) | Beijing 302 Hospital | 2020-08-15 |
| CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis (NCT04512833) | Beijing 302 Hospital | 2020-08-12 |
| Comparison of Efficacy in SBRT of Large HCC With or Without TACE (NCT04512846) | Beijing 302 Hospital | 2020-08-01 |
| Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) (NCT04288102) | Beijing 302 Hospital | 2020-03-05 |
| Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 (NCT04252118) | Beijing 302 Hospital | 2020-01-27 |
| Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection (NCT04251871) | Beijing 302 Hospital | 2020-01-22 |
| Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE (NCT04161287) | Beijing 302 Hospital | 2019-10-11 |
| Allogeneic Adoptive Immune Therapy for Advanced AIDS Patients (NCT04098770) | Beijing 302 Hospital | 2019-10-11 |
| Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells (NCT04032392) | Beijing 302 Hospital | 2019-07-23 |
| Outcome of Tucidinostat-Based Therapy in HR+ Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitor (NCT05276713) | Beijing 302 Hospital | 2019-07-10 |
| Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis (NCT03945487) | Beijing 302 Hospital | 2019-05-20 |
| TCR-Redirected T Cells Therapy in Patient With HBV Related HCC (NCT03899415) | Beijing 302 Hospital | 2019-04-20 |
| Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma (NCT04162158) | Beijing 302 Hospital | 2019-03-01 |
| Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment (NCT03577938) | Beijing 302 Hospital | 2019-01-10 |
| On the Cyberknife Dose Fraction of Liver Cancer Treatment (NCT03295500) | Beijing 302 Hospital | 2017-11-01 |
| 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI (NCT03266146) | Beijing 302 Hospital | 2017-09-02 |